Skip to main content
Log In
Sign Up
Home
Stocks
Stock Screener
Stock Exchanges
Comparison Tool
Earnings Calendar
By Industry
Stock Lists
Top Analysts
Top Stocks
Corporate Actions
IPOs
Recent IPOs
IPO Calendar
IPO Statistics
IPO News
IPO Screener
ETFs
ETF Screener
Comparison Tool
New Launches
ETF Providers
News
Trending
Articles
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After Hours
Market Newsletter
Stock Analysis Pro
Watchlist
Collapse
Home
»
Analysts
»
Farzin Haque
Farzin Haque
Stock Analyst at Jefferies
(3.01)
# 1,401
Out of 4,682 analysts
2
Total ratings
50%
Success rate
116.9%
Average return
Main Sectors:
Healthcare
Top Industries:
Biotechnology
Stocks Rated by Farzin Haque
Stock
Action
Price Target
Current
Upside
Ratings
Updated
PYXS
Pyxis Oncology
Assumes:
Buy
$10
$1.86
+437.63%
1
May 7, 2024
VERA
Vera Therapeutics
Upgrades:
Buy
$18
→
$26
$49.50
-47.47%
1
Nov 10, 2023
PYXS
Pyxis Oncology
May 7, 2024
Assumes:
Buy
Price Target:
$10
Current: $1.86
Upside:
+437.63%
1 Ratings
View All
VERA
Vera Therapeutics
Nov 10, 2023
Upgrades:
Buy
Price Target:
$18
→
$26
Current: $49.50
Upside:
-47.47%
1 Ratings
View All